Related Experiment Video
Updated: Jan 6, 2026

05:21
Author Spotlight: Optimizing Antibody-Based Cancer Treatments via Antibody-Dependent, Cell-Mediated Cytotoxicity Assay
Published on: September 13, 2024
791
The Immuno-oncology-Induced Cytokine Release Syndrome Patient Diary: A Content-Valid, Patient-Reported Outcome
Edward Ted Wells1, Laurence Lucats2, Giovanni Abbadessa3
1IQVIA, Strategy and Life Sciences Consulting, Durham, NC, USA. edward.wells@iqvia.com.
Oncology and Therapy
|October 3, 2025
Summary
A new patient diary was developed to standardize the reporting of cytokine release syndrome (CRS) symptoms and impacts in immuno-oncology trials. This tool captures patient experiences, improving understanding of CRS beyond clinical assessments.
Area of Science:
- Oncology
- Immunology
- Clinical Research
Background:
- Cytokine release syndrome (CRS) is a systemic inflammatory response to infections or immunotherapies.
- CRS symptoms vary widely, from mild to life-threatening.
- Standardized patient-reported data collection for CRS is currently lacking.
Purpose of the Study:
- To develop a novel patient-reported outcome measure (PROM) for capturing patient experiences with CRS.
- To create a standardized tool for monitoring CRS in clinical trials.
Main Methods:
- A comprehensive process including literature review, analysis of clinical trial data, expert interviews, and patient interviews.
- Development of a preliminary conceptual model and iterative refinement through workshops and cognitive debriefing.
Main Results:
- Identification of various CRS signs and symptoms from literature and clinical data.
- Development and refinement of the immuno-oncology (IO)-induced CRS patient diary through expert and patient feedback.
- The diary effectively captures CRS symptom incidence, severity, and impact.
Conclusions:
- The "IO-induced CRS patient diary" is a content-valid tool for monitoring CRS symptoms and impacts in IO clinical trials.
- This PROM offers a standardized patient perspective on IO-induced CRS.
- It addresses the need for consistent assessment beyond traditional clinical evaluations.
Keywords:
CAR-T therapyCRSCRS impactCytokine release syndromeIO therapyImmuno-oncology therapyPROMPatient diaryPatient interviewsPatient-reported outcome measureMore Related Videos
Related Concept Videos
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Bioavailability Study Design: Healthy Subjects Versus Patients
126
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
126

